Bayesian approach to the imputability of undesirable phenomena to drugs
Auriche, M.
Therapie 40(5): 301-306
1985
ISSN/ISBN: 0040-5957 PMID: 4095686 Document Number: 255221
Document emailed within 1 workday
Related Documents
Villette, B.; Rybojad, M.; Puissant, A. 1989: Dermatologic manifestation of undesirable effects of drugs (excluding cytostatic drugs) Annales de Medecine Interne 140(7): 609-613Evreux, J.C.; Loupi, E.; Descotes, J.; Ventre, J.J. 1982: Evaluation of the documentation on adverse effects of drugs. Proposition. 2. Imputability Therapie 37(6): 657-670
Albin, H.; Begaud, B.; Boisseau, A.; Dangoumau, J. 1980: Utilization of the imputability method for validating publications on side effects of drugs Therapie 35(5): 571-576
Royer, R.J.; Netter, P.; Trechot, P. 1989: Mechanisms of undesirable effects of drugs Annales de Medecine Interne 140(7): 618-619
Assunção, R.M.; Barreto, S.M.; Guerra, H.L.; Sakurai, E. 1998: Maps of epidemiological rates: a Bayesian approach Cadernos de Saude Publica 14(4): 713-723
Cheymol, G.; Biour, M. 1983: The pharmacokinetic basis of of the undesirable effects of drugs in the aged subject Therapie 38(5): 475-484
Péré, J.C.; Begaud, B.; Haramburu, F.; Albin, H. 1984: Methods for studying the adverse effects of drugs. I. Comparison of imputability methods: modelling and methodology Therapie 39(3): 279-289
Zannou, D.M.; Houngbè, F.; Acapko, J.; Adé, G.; Gougounou, A.; Akondé, A. 2007: Undesirable effect of antiretroviral drugs in patients infected with HIV at Cotonou Benin Le Mali Medical 22(1): 37-43
Zannou, D.M.; Houngbè, F.; Acapko, J.; Adé, G.; Gougounou, A.; Akondé, A. 2007: Undesirable effect of antiretroviral drugs in patients infected with HIV at Cotonou Benin Le Mali Medical 22(1): 37-43
De Santis, F.; Perone Pacifico, M. 2004: Accounting for historical information in designing experiments: the Bayesian approach Annali Dell'istituto Superiore di Sanita 40(2): 173-179
Lechat, P. 1974: Periodical re-evaluation of the undesirable side effects of old drugs. An important mission of drug surveillance La Nouvelle Presse Medicale 3(24): 1571-1573
Hische, E.A.; van der Helm, H.J.; van Walbeek, H.K. 1982: The cerebrospinal fluid immunoglobulin G index as a diagnostic aid in multiple sclerosis: a Bayesian approach Clinical Chemistry 28(2): 354-355
Li, Q.; Louis, T.A.; Liu, L.; Wang, C.; Tsui, A.O. 2019: Subnational estimation of modern contraceptive prevalence in five sub-Saharan African countries: a Bayesian hierarchical approach Bmc Public Health 19(1): 216
Appel, G. 1974: An approach to the treatment of schizoid phenomena Psychoanalytic Review 61(1): 99-113
Macnab, Y.C. 2009: Bayesian multivariate disease mapping and ecological regression with errors in covariates: Bayesian estimation of DALYs and 'preventable' DALYs Statistics in Medicine 28(9): 1369-1385
Abkai, C.; Hesser, J.ür. 2009: Virtual intensive care unit (ICU): real-time simulation environment applying hybrid approach using dynamic Bayesian Networks and ODEs Studies in Health Technology and Informatics 142: 1-6
Baker, R.A.; Pikalov, A.; Tran, Q-Van.; Kremenets, T.; Arani, R.B.; Doraiswamy, P.Murali. 2009: Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis Psychopharmacology Bulletin 42(1): 11-31
Truelle, J.L.; Chanelet, J.; Bastard, J.; Emile, J. 1975: Polygraphic recording of tremor and of hypertonic phenomena. Application to the action of various drugs Revue Neurologique 131(1): 29-42
Carabin, Hélène.; Escalona, M.; Marshall, C.; Vivas-Martínez, S.; Botto, C.; Joseph, L.; Basáñez, Mía-Gloria. 2003: Prediction of community prevalence of human onchocerciasis in the Amazonian onchocerciasis focus: Bayesian approach Bulletin of the World Health Organization 81(7): 482-490
Gallo, G.; Clemenzia, G. 1971: Anaerobic phenomena in plants. II. Experimental studies on the relationships between anaerobiosis phenomena and catalase in caryopses of Oryza sativa Rivista di Biologia 64(3): 397-411